Welcome to THC Science

Bringing Science to the Cannabis Conversation!

What is the Difference Between Hemp and Cannabis?

Rimonabant RimonabantClinical dataAHFS/Drugs.comConsumer Drug InformationLicense data EU EMA: by INN Pregnancycategory Not assigned, use not recommended Routes ofadministrationOralATC codeA08AX01 (WHO) Legal statusLegal status Withdrawn from European and Brazilian markets; not approved elsewhere[1][2] Pharmacokinetic dataBioavailabilityUndeterminedProtein bindingNearly 100%MetabolismHepatic, CYP3A4 involvedElimination half-lifeVariable:6 to 9 days with normal BMI16 days if BMI >30ExcretionFecal (86%) and renal (3%)Identifiers IUPAC name 5-(4-Chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide CAS Number158681-13-1 YPubChem CID104850IUPHAR/BPS743DrugBankDB06155 YChemSpider94641 YUNIIRML78EN3XEKEGGD05731 YChEMBLChEMBL111 YCompTox… read more »

Research

Rimonabant RimonabantClinical dataAHFS/Drugs.comConsumer Drug InformationLicense data EU EMA: by INN Pregnancycategory Not assigned, use not recommended Routes ofadministrationOralATC codeA08AX01 (WHO) Legal statusLegal status Withdrawn from European and Brazilian markets; not approved elsewhere[1][2] Pharmacokinetic dataBioavailabilityUndeterminedProtein bindingNearly 100%MetabolismHepatic, CYP3A4 involvedElimination half-lifeVariable:6 to 9 days with normal BMI16 days if BMI >30ExcretionFecal (86%) and renal (3%)Identifiers IUPAC name 5-(4-Chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide CAS Number158681-13-1 YPubChem CID104850IUPHAR/BPS743DrugBankDB06155 YChemSpider94641 YUNIIRML78EN3XEKEGGD05731 YChEMBLChEMBL111 YCompTox… read more »

THC Science Mission to Share Cannabis Science with the World

Rimonabant RimonabantClinical dataAHFS/Drugs.comConsumer Drug InformationLicense data EU EMA: by INN Pregnancycategory Not assigned, use not recommended Routes ofadministrationOralATC codeA08AX01 (WHO) Legal statusLegal status Withdrawn from European and Brazilian markets; not approved elsewhere[1][2] Pharmacokinetic dataBioavailabilityUndeterminedProtein bindingNearly 100%MetabolismHepatic, CYP3A4 involvedElimination half-lifeVariable:6 to 9 days with normal BMI16 days if BMI >30ExcretionFecal (86%) and renal (3%)Identifiers IUPAC name 5-(4-Chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide CAS Number158681-13-1 YPubChem CID104850IUPHAR/BPS743DrugBankDB06155 YChemSpider94641 YUNIIRML78EN3XEKEGGD05731 YChEMBLChEMBL111 YCompTox… read more »

Sidebar